Guardian Pharmacy Services Past Earnings Performance
Past criteria checks 0/6
Guardian Pharmacy Services's earnings have been declining at an average annual rate of -22.1%, while the Consumer Retailing industry saw earnings growing at 13.2% annually. Revenues have been growing at an average rate of 11.1% per year.
Key information
-22.1%
Earnings growth rate
n/a
EPS growth rate
| Consumer Retailing Industry Growth | 10.9% |
| Revenue growth rate | 11.1% |
| Return on equity | -51.0% |
| Net Margin | -8.4% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How Guardian Pharmacy Services makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 1,171 | -98 | 296 | 0 |
| 30 Jun 24 | 1,119 | 24 | 189 | 0 |
| 31 Mar 24 | 1,085 | 29 | 168 | 0 |
| 31 Dec 23 | 1,046 | 24 | 167 | 0 |
| 30 Sep 23 | 1,002 | 12 | 161 | 0 |
| 30 Jun 23 | 976 | 23 | 135 | 0 |
| 31 Mar 23 | 947 | 19 | 158 | 0 |
| 31 Dec 22 | 909 | 35 | 134 | 0 |
| 30 Sep 22 | 882 | 19 | 153 | 0 |
| 31 Mar 22 | 822 | 34 | 122 | 0 |
| 31 Dec 21 | 792 | 16 | 131 | 0 |
| 30 Sep 21 | 771 | 31 | 101 | 0 |
| 31 Mar 21 | 732 | 21 | 100 | 0 |
| 31 Dec 20 | 736 | 20 | 103 | 0 |
| 30 Sep 20 | 730 | 16 | 108 | 0 |
| 31 Dec 19 | 698 | 22 | 98 | 0 |
| 30 Sep 19 | 677 | 17 | 98 | 0 |
| 31 Dec 18 | 600 | 15 | 88 | 0 |
Quality Earnings: GRDN is currently unprofitable.
Growing Profit Margin: GRDN is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: GRDN is unprofitable, and losses have increased over the past 5 years at a rate of 22.1% per year.
Accelerating Growth: Unable to compare GRDN's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: GRDN is unprofitable, making it difficult to compare its past year earnings growth to the Consumer Retailing industry (10.8%).
Return on Equity
High ROE: GRDN has a negative Return on Equity (-51.02%), as it is currently unprofitable.